This free session recording is sponsored by Veracyte. 
.
Presented by Virginia LiVolsi, MD and Maria Gubbiotti, MD on April 25, 2023
Approximately 50% of Americans will develop a thyroid nodule by the time they’re 60 years old. While most are benign, 5% are cancerous. This session will provide an overview of recent updates in the classification of thyroid tumors and the impact on clinical management.
Learning Objectives
At the end of this session, the attendee will be able to:
- Describe newly defined thyroid tumors
- Discuss the history of NIFTP, a reclassified thyroid tumor, and its impact on clinical management
- Differentiate between high grade and poorly differentiated thyroid tumors
CE ACCREDITATION
ASCLS is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. One (1) P.A.C.E. ® contact hour and one (1) Florida credit hour in the area of General will be awarded to participants. ASCLS P.A.C.E.® is accepted by the ASCP/ASCLS/AGT Board of Certification and all states, including Florida and California, as an approved provider of continuing education for recertification and licensure. ASCLS is an approved provider with CE Broker for Florida licensees.
LEVEL OF INSTRUCTION
This intermediate-level program is appropriate for laboratory professionals working in clinical, public health and academic settings.
ASCLS is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program.